Figure 2.
The 100-day incidence of infection after CAR T-cell therapy. (A) Any infection, (B) bacterial infection, (C) viral infection, and (D) fungal infection.
The 100-day incidence of infection after CAR T-cell therapy. (A) Any infection, (B) bacterial infection, (C) viral infection, and (D) fungal infection.
